Project Grant R01TW007939

This Project Grant award for $412,656.00 from the National Institute on Aging (part of the National Institutes of Health, CFDA 93.866 Aging Research) will develop new statistical methods and data collection tools to estimate adult mortality rates in low- and middle-income countries using surveys with moderate sample sizes. The project aims to create innovative approaches that can accurately measure adult death rates using surveys of 1,000-2,000 individuals, a significant improvement over current...

This $2,490,060 Cooperative Agreement award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) supports research to optimize public health communication strategies on the relative risks of tobacco products. The project aims to generate effective messaging on the continuum of tobacco product risks, assess their impact on message response, receptivity, and behavioral precursors,...

This Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), will fund a three-year, $515,632 research project to estimate the impact of potential U.S. Food and Drug Administration (FDA) cigarette product standards on smoking cessation rates in each U.S. state. The key objectives are to: 1) Estimate the number of people who smoke, including priority populations, who will quit smoking and enroll in state quitlines in...

This Project Grant award from the National Cancer Institute (NCI), under the Cancer Research Manpower (CFDA 93.398) program, provides $129,708 to Purdue University to examine the impact of local tobacco retail policies on sociodemographic disparities in tobacco use. The key objectives are to: 1) Analyze the effect of tobacco retailer licensing laws and fees on differences in retailer density by race/ethnicity, income, and education; 2) Measure the impact of flavored tobacco product...

This National Institute on Minority Health and Health Disparities (NIMHD) Project Grant award under the Minority Health and Health Disparities Research (CFDA 93.307) program aims to evaluate population-based strategies for improving smoking cessation rates among rural populations. The $694,771 award to the Regents of the University of Minnesota will fund a randomized controlled trial to determine the efficacy of providing rural people who smoke with a free nicotine replacement therapy (NRT)...

This federal Project Grant award for $226,504 was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393). The award to George Washington University will support research to examine tobacco use behaviors and related mechanisms over time among U.S. adults and youth representing minority and intersecting minority identities, such as racial/ethnic minorities, sexual/gender minorities, low socioeconomic status, and rural populations. The...

This $801,832 Project Grant, awarded by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310), aims to reduce disparities and the burden of lung cancer among African American smokers. The grant supports a multilevel intervention integrating lung cancer screening and smoking cessation (MILS) to investigate smokers' and providers' attitudes, knowledge, and experiences with the expanded 2021 U.S. Preventive Services Task Force lung cancer screening...

This Project Grant award of $1,951,307 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Medical University of South Carolina (MUSC). The funding will support a longitudinal cohort study investigating the use patterns and trajectories of dual users of combustible and electronic cigarettes, to better understand how these patterns relate to smoking cessation. The study, led by researchers at MUSC and the University...

This $661,139 federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports a 6-year study by The Ohio State University on the use of oral nicotine pouches (ONPs) to help reduce smoking-related cancer disparities in rural Appalachia. The project involves a randomized trial with 1,000 adult smokers in rural Appalachia, where participants will be assigned to either use ONPs or nicotine replacement therapy (NRT) products to attempt...

This National Cancer Institute (NCI) research project grant under the Cancer Cause and Prevention Research program (CFDA 93.393) is designed to explore consumer responses to the FDA's new authorizations allowing certain smokeless tobacco products to make modified risk claims in their marketing. The $885,824 grant, awarded to Health Research, Inc. at Roswell Park in Buffalo, NY, will fund a series of complementary research activities over a 2-year period from August 2024 to July 2026. The key...